HeartSciences and Icahn Mount Sinai have also entered into a memorandum of understanding for ongoing cooperation encompassing de-identified data access
News | Artificial Intelligence
HeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular Algorithms

September 21, 2023 — Heart Test Laboratories, Inc., an AI-powered medical technology company focused on transforming ...

Home September 21, 2023
Home
IDE supported by data from the MODERATO II randomized pilot study that showed AVIM therapy drove significant and sustained reductions in blood pressure in hypertensive pacemaker patients
News | Hypertension
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT for the Treatment of Hypertension in Pacemaker Patients

September 20, 2023 — Orchestra BioMed Holdings, Inc., a biomedical company accelerating high-impact technologies to ...

Home September 20, 2023
Home
IDE supported by data from the MODERATO II randomized pilot study that showed AVIM therapy drove significant and sustained reductions in blood pressure in hypertensive pacemaker patients
News | Heart Valve Technology
Minneapolis Heart Institute Foundation Launches the PROGRESS Clinical Trial to Examine the Safety and Effectiveness of Transcatheter Valve Replacement in Patients with Moderate, Calcific Aortic Stenosis

September 20, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...

Home September 20, 2023
Home
All pregnant people should have their blood pressure measured at each prenatal visit
News | Hypertension
Task Force Issues Final Recommendation Statement on Screening for Hypertensive Disorders of Pregnancy

September 20, 2023 — The U.S. Preventive Services Task Force (Task Force) published a final recommendation statement on ...

Home September 20, 2023
Home
SmartCardia has received FDA clearance for its 7-lead real-time ECG monitoring patch and cloud platform
News | Wearables
SmartCardia Receives FDA Clearance for its 14-Day 7-Lead ECG Real-Time Patch and Cloud Platform

September 19, 2023 — SmartCardia has received FDA clearance for its 7-lead real-time ECG monitoring patch and cloud ...

Home September 19, 2023
Home
An advanced CT test can identify individuals with stable angina at a reduced risk of three-year adverse outcomes despite their having a high coronary artery calcium score
News | Computed Tomography (CT)
CT Test Simulates Blood Flow to Assess Risk in Patients with Angina

September 19, 2023 — An advanced CT test can identify individuals with stable angina at a reduced risk of three-year ...

Home September 19, 2023
Home
The results of the iHEART project have been published in the prestigious journal 'Nature Scientific Reports'
News | Cardiovascular Clinical Studies
iHEART Simulator, a Mathematical Model of the Heart to Revolutionize Cardiac Research

September 19, 2023 — A mathematical and computational model of the human heart entirely developed at Politecnico di ...

Home September 19, 2023
Home
Smidt Heart Institute investigators found the rise in illicit substance abuse in pregnancy is associated with significantly high risk of cardiovascular events, maternal mortality
News | Cardiovascular Clinical Studies
Substance Abuse in Pregnancy Doubles Cardiovascular Risk

September 18, 2023 — Pregnant women with a history of substance abuse face a dramatically increased risk of death from ...

Home September 18, 2023
Home
Study will evaluate the safety and effectiveness of the OMNYPULSE Pulsed Field Ablation (PFA) platform with integrated mapping
News | Cardiovascular Clinical Studies
Biosense Webster Begins Evaluation of Large-tip Focal Pulsed Field Ablation Catheter in Omny-IRE Clinical Trial in Europe

September 18, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home September 18, 2023
Home
Abelacimab, a Dual-Acting Factor XI / XIa Inhibitor, Demonstrated an Unprecedented Reduction in Bleeding in the Largest and Longest Head-toHead Study Comparing a Factor XI Inhibitor to a DOAC
News | Cardiovascular Clinical Studies
Atrial Fibrillation Study with Abelacimab Stopped Early by the Data Monitoring Committee Due to an Overwhelming Reduction in Bleeding as Compared to a DOAC

September 18, 2023 — Anthos Therapeutics, Inc., a clinical stage company developing innovative therapies for ...

Home September 18, 2023
Home
Investigational device for treating tricuspid valve regurgitation implanted using non-surgical procedure
News | Heart Failure
Henry Ford Health Patient First in the US to Receive New Heart Failure Technology

September 15, 2023 — A team of interventional cardiologists from Henry Ford Health’s Center for Structural Heart Disease ...

Home September 15, 2023
Home
US adults with prior traumatic brain injury (TBI) had an estimated 32% higher stroke risk over a 30-year study period
News | Stroke
Even Mild Head Injury Increases the Risk of Ischemic Stroke, Study Shows

September 15, 2023 — Suffering a traumatic brain injury (TBI) – no matter how severe – is associated with a ...

Home September 15, 2023
Home
They are the only hospitals in New Jersey to earn this elite distinction and provide world-class patient care through a sustainable quality improvement program
News | Cardiovascular Business
Five Hackensack Meridian Hospitals Nationally Recognized for Excellence with ACC HeartCARE Center Designations

September 15, 2023 — The American College of Cardiology (ACC) has recognized five Hackensack Meridian Health hospitals ...

Home September 15, 2023
Home
Contrast enhanced ultrasound (CEUS) is underutilized in the United States
News | Ultrasound Imaging
CEUS Underutilization May Pose Greater Risk Than Rare Side Effects Associated With Use, Say Experts

September 15, 2023 — Contrast enhanced ultrasound (CEUS) is underutilized in the United States, and reduced access to ...

Home September 15, 2023
Home
New therapeutic option has potential to reduce rate of major limb amputation in US
News | Peripheral Artery Disease (PAD)
FDA Approves LimFlow System in Patients with Chronic Limb-threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options

September 14, 2023 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of ...

Home September 14, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now